Duodopa

Duodopa is a subcutaneous medication containing foscarbidopa and foslevodopa, used for managing motor fluctuations in Parkinson's disease. This therapy is designed for continuous delivery via a portable pump system.

Duodopa is primarily used to treat motor fluctuations in patients with advanced Parkinson's disease. The combination of foscarbidopa and foslevodopa helps manage symptoms such as tremors, stiffness, and difficulty moving. This medication is administered through a subcutaneous infusion, providing a steady supply of the active ingredients to the body. Patients who have not responded well to oral medications may find relief with Duodopa.

Common effects of Duodopa may include injection site reactions, nausea, and dizziness. Some users might experience changes in blood pressure or hallucinations. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Duodopa should be handled with care to avoid contamination. The infusion site should be cleaned and rotated regularly to prevent infections. Patients should be aware of the risks associated with subcutaneous administration, such as skin irritation or allergic reactions. Always follow the instructions provided by the healthcare provider for safe and effective use.

Duodopa may interact with other medications, including those that affect dopamine levels or blood pressure. Alcohol and certain foods may also influence its effectiveness. It is important to discuss all current medications and supplements with a healthcare provider to avoid potential interactions.